cGxP.wire https://validator.w3.org/feed/docs/rss2.html Nasus Pharma Reports Positive Preclinical Results for NS003 Arima Genomics Reports Hi-C Outperforms Whole Genome Sequencing Guardant Health Secures FDA Nod for HER2-Mutant NSCLC Diagnostic JW Pharmaceutical Showcases DDC-02 Potential Across Multiple Rare Neurodevelopmental Disorders at WODC USA 2026 Genmab Reports Positive EPCORE FL-1 Data for Epcoritamab Combination Heartseed Initiates World’s First Catheter-Based iPS Heart Therapy Study Sanofi’s Tzield Gains FDA Approval in Stage 3 Type 1 Diabetes AbbVie Reports 9-Year VENCLEXTA Data in First-Line CLL Jazz Reports Phase 3 LAGOON Results for Zepzelca in SCLC Volta Labs Automates Twist’s Full Hybrid Capture Portfolio on Callisto GlycoNex Reports Positive Phase III Results for SPD8 Biosimilar Wave Neuroscience Wins FDA Clearance for MeRT in PTSD Novo Nordisk Secures UK Approval for First Wegovy Weight-Loss Pill Simcere and Stanford Partner on Novel IPF Therapy Research Novartis Advances First Targeted Therapy for Chronic Inducible Urticaria XtalPi Advances AI-Powered Drug Discovery Through $400M GPCR Collaboration Akeso Wins NMPA Approval for Gumokimab in Plaque Psoriasis FDA Grants Priority Review to Genentech’s Tecentriq for Early Colon Cancer Merck Animal Health Acquires TARGAN to Advance Poultry Technology Penumbra Gains FDA Approval for THUNDERBOLT Thrombectomy System ZYUS Life Sciences Realigns Operations to Advance Non-Opioid Drug Pipeline Xeris Pharmaceuticals Receives USPTO Patent Allowance for KEVEYIS Roche Expands VENTANA MMR Companion Diagnostic Across Multiple Cancer Types Airiver Treats First Patient in Pivotal CRS Balloon Trial Roche’s Tecentriq Receives FDA Priority Review for Stage III Colon Cancer DKSH and BridgeBio Partner to Expand ATTR-CM Treatment Access Elixiron Reports Positive Phase 2 Enrupatinib Data in Alzheimer’s Disease Takeda’s Zasocitinib Outperforms Deucravacitinib in Psoriasis Johnson & Johnson’s IMAAVY Delivers Breakthrough Results in wAIHA Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies Formosa Pharma Expands APP13007 Reach Through Samil Deal Enliven Therapeutics Reports Positive ELVN-001 Phase 1 Data Anixa Biosciences Highlights Clinical Immunotherapy Progress at Cancer Symposium Certified Group Achieves FDA Acceptance for Seafood PFAS Analysis Evaxion Presents New Preclinical Data for EVX-04 in Acute Myeloid Leukemia BioInvent’s TNFR2 Antibody BI-1808 Shows Promising Responses in Advanced CTCL at EHA 2026 Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Eti-cel Data at EHA 2026 Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics Matter Bio Wins FDA IND Clearance for LM-LLO-TT Trial SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy Oncolys BioPharma Secures Japan Approval for Telomelysin in Esophageal Cancer FDA Approves New Sunscreen Ingredient After Two Decades Takeda’s ENTYVIO Nears Pediatric IBD FDA Approval Philips Finds AI Boosting Patient Access and Clinical Efficiency Worldwide HERVolution Advances Immune Therapy for Metabolic Disease Sonex Health Reports Largest U.S. Study Supporting UltraGuideCTR for Carpal Tunnel Subtle Medical Secures FDA Clearance for AI-Powered SubtleHD CT Curium Completes Phase 2 Dosing for 64Cu-PSMA-I&T in Japan Novartis Del-Brax Shows Breakthrough Potential in FSHD